About this item:

313 Views | 240 Downloads

Author Notes:

Corresponding Author: Lisa Haddad, MD MS MPH, Assistant Professor, Department of Gynecology and Obstetrics, 49 Jesse Hill Jr. Drive NE, 3rd Floor, Faculty office building, Atlanta, GA 30303, Phone: 404-778-1385.


Research Funding:

Supported in part by PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, National Institutes of Health, National Center for Advancing Translational Sciences.

The authors would also like to acknowledge the additional funding support provided by the Emory University School of Medicine, Department of Gynecology and Obstetrics via the 2016-2017 Marianne Ruby Award.


  • Science & Technology
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Multipurpose prevention technologies
  • HIV prophylaxis
  • STIs
  • Contraception
  • HIV

Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States


Journal Title:



Volume 97, Number 3


, Pages 277-284

Type of Work:

Article | Post-print: After Peer Review


Objective: High rates of sexually transmitted infections (STIs) and unintended pregnancy suggest a role for multipurpose prevention technologies (MPTs) designed to combine contraception and infection prophylaxis into one unified method. This study aims to determine factors associated with interest in MPTs among US women. Study Design: We administered a national cross-sectional survey via MTurk. Eligibility criteria included female gender, age 18–29 years, residence in the USA, and sexual activity with a male partner in the past three months. In total, 835 surveys were suitable for analysis. Bivariable and multivariable logistic regressions were performed to determine factors associated with interest in MPTs. Results: Eighty-three percent of women were interested in MPTs. Factors associated with interest included oral sex in the past three months (aOR 1.87, 95% CI 1.07, 3.53), recent use of oral contraceptive pills (OCPs; aOR 1.78, 95% CI 1.08, 2.93), HIV test within one year (aOR 2.10, 95% CI 1.29, 3.40), and increased STI worry score (aOR 1.98, 95% CI 1.36, 2.86). No use of contraception in the past three months was associated with decreased interest in MPTs (aOR 0.31, 95% CI 0.17, 0.58). HIV risk factors including race were not associated with MPT interest. Conclusion: Our data show that young, sexually active, US women are interested in MPTs. Women who used contraception, specifically OCPs, or evidenced concern for infection were most likely to be interested in such a product. Women reporting unsafe sexual habits were less likely to be interested, highlighting the importance of HIV/STI prevention education. Implications: Women in the USA are interested in multipurpose prevention technologies, particularly those women who currently use contraception or are concerned about their risk of infection. Our results emphasize the importance of moving forward with MPT development as well as continued HIV/STI prevention education.

Copyright information:

© 2017 Elsevier Inc.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote